Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
Identifieur interne : 000A73 ( Ncbi/Curation ); précédent : 000A72; suivant : 000A74Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
Auteurs : Philip E. Lee [Canada] ; Sudeep S. Gill [Canada] ; Paula Rochon [Canada]Source :
- Neuropsychiatric Disease and Treatment [ 1176-6328 ] ; 2006.
Abstract
Neuropsychiatric symptoms are common in older adults with dementia and can be associated with a rapid decline in cognitive and functional status. This article reviews the current literature supporting the use of atypical antipsychotic medications in this population. Among the currently available atypical antipsychotics, risperidone and olanzapine have been the most widely studied in double-blind, randomized, placebo-controlled clinical trials. Despite the common use of other atypical antipsychotic medications, their efficacy and safety in older adults with dementia has not been as extensively studied. Some controversy surrounds the use of atypical antipsychotic agents in older adults with the suggestion that they may increase the incidence of stroke or even death. Despite the potential for increased risk of harm from the use of these medications, atypical antipsychotics are often effective in treating troublesome neuropsychiatric symptoms refractory to other treatments. Whenever possible, these atypical antipsychotic drug treatments should be combined with non-pharmacological treatments to limit the need and dose of antipsychotic drugs and constant monitoring for potential harms should be maintained. The choice of which atypical antipsychotic agent can be guided by the nature and severity of the target symptom and the medication least likely to cause harm to the patient.
Url:
PubMed: 19412500
PubMed Central: 2671943
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C91
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000C91
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000C37
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000A73
Links to Exploration step
PMC:2671943Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia</title><author><name sortKey="Lee, Philip E" sort="Lee, Philip E" uniqKey="Lee P" first="Philip E" last="Lee">Philip E. Lee</name><affiliation wicri:level="1"><nlm:aff id="af1-ndt-2-521">Division of Geriatric Medicine, University of British Columbia, BC, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Geriatric Medicine, University of British Columbia, BC</wicri:regionArea><wicri:noRegion>BC</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="af3-ndt-2-521">Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences (ICES), Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Gill, Sudeep S" sort="Gill, Sudeep S" uniqKey="Gill S" first="Sudeep S" last="Gill">Sudeep S. Gill</name><affiliation wicri:level="1"><nlm:aff id="af2-ndt-2-521">Department of Medicine, Queen’s University, Kingston, ON, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Medicine, Queen’s University, Kingston, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="af3-ndt-2-521">Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences (ICES), Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Rochon, Paula" sort="Rochon, Paula" uniqKey="Rochon P" first="Paula" last="Rochon">Paula Rochon</name><affiliation wicri:level="1"><nlm:aff id="af3-ndt-2-521">Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences (ICES), Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="af4-ndt-2-521">Kunin-Lunenfeld Applied Research Unit, Toronto, ON, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Kunin-Lunenfeld Applied Research Unit, Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">19412500</idno><idno type="pmc">2671943</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671943</idno><idno type="RBID">PMC:2671943</idno><date when="2006">2006</date><idno type="wicri:Area/Pmc/Corpus">000C91</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000C91</idno><idno type="wicri:Area/Pmc/Curation">000C91</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000C91</idno><idno type="wicri:Area/Pmc/Checkpoint">000C37</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000C37</idno><idno type="wicri:Area/Ncbi/Merge">000A73</idno><idno type="wicri:Area/Ncbi/Curation">000A73</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia</title><author><name sortKey="Lee, Philip E" sort="Lee, Philip E" uniqKey="Lee P" first="Philip E" last="Lee">Philip E. Lee</name><affiliation wicri:level="1"><nlm:aff id="af1-ndt-2-521">Division of Geriatric Medicine, University of British Columbia, BC, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Geriatric Medicine, University of British Columbia, BC</wicri:regionArea><wicri:noRegion>BC</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="af3-ndt-2-521">Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences (ICES), Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Gill, Sudeep S" sort="Gill, Sudeep S" uniqKey="Gill S" first="Sudeep S" last="Gill">Sudeep S. Gill</name><affiliation wicri:level="1"><nlm:aff id="af2-ndt-2-521">Department of Medicine, Queen’s University, Kingston, ON, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Medicine, Queen’s University, Kingston, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="af3-ndt-2-521">Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences (ICES), Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Rochon, Paula" sort="Rochon, Paula" uniqKey="Rochon P" first="Paula" last="Rochon">Paula Rochon</name><affiliation wicri:level="1"><nlm:aff id="af3-ndt-2-521">Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada;</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences (ICES), Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="af4-ndt-2-521">Kunin-Lunenfeld Applied Research Unit, Toronto, ON, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Kunin-Lunenfeld Applied Research Unit, Toronto, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author></analytic><series><title level="j">Neuropsychiatric Disease and Treatment</title><idno type="ISSN">1176-6328</idno><idno type="eISSN">1178-2021</idno><imprint><date when="2006">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Neuropsychiatric symptoms are common in older adults with dementia and can be associated with a rapid decline in cognitive and functional status. This article reviews the current literature supporting the use of atypical antipsychotic medications in this population. Among the currently available atypical antipsychotics, risperidone and olanzapine have been the most widely studied in double-blind, randomized, placebo-controlled clinical trials. Despite the common use of other atypical antipsychotic medications, their efficacy and safety in older adults with dementia has not been as extensively studied. Some controversy surrounds the use of atypical antipsychotic agents in older adults with the suggestion that they may increase the incidence of stroke or even death. Despite the potential for increased risk of harm from the use of these medications, atypical antipsychotics are often effective in treating troublesome neuropsychiatric symptoms refractory to other treatments. Whenever possible, these atypical antipsychotic drug treatments should be combined with non-pharmacological treatments to limit the need and dose of antipsychotic drugs and constant monitoring for potential harms should be maintained. The choice of which atypical antipsychotic agent can be guided by the nature and severity of the target symptom and the medication least likely to cause harm to the patient.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A73 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000A73 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= PMC:2671943
|texte= Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:19412500" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |